Stock FORZ FORZA INNOVATIONS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Forza Innovations Inc.

Equities

FORZ

US34987W1053

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 03:17:32 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Forza Innovations Inc. 0.00% -66.67%
Feb. 13 Forza Innovations Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Jan. 17 Forza Innovations Inc. Reports Earnings Results for the Full Year Ended June 30, 2023 CI

Valuation

Fiscal Period: June 2020 2021 2022 2023
Capitalization 1 2.19 224.8 1.892 0.273
Enterprise Value (EV) 1 2.721 225.1 2.543 2.102
P/E ratio -6.74 x -58.6 x -0.91 x -0.03 x
Yield - - - -
Capitalization / Revenue 3.62 x - 73.1 x 2.38 x
EV / Revenue 4.49 x - 98.3 x 18.3 x
EV / EBITDA 57.9 x -4,330 x -1.36 x -2.43 x
EV / FCF -17.3 x -281,392 x 3.26 x -
FCF Yield -5.79% -0% 30.7% -
Price to Book 43.2 x -768 x -1.42 x -0.06 x
Nbr of stocks (in thousands) 182,500 281,000 220,010 1,364,972
Reference price 2 0.0120 0.8000 0.008600 0.000200
Announcement Date 5/4/21 10/12/21 10/13/22 1/17/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.2369 0.7688 0.6054 - 0.0259 0.1146
EBITDA 1 -0.0566 0.2033 0.047 -0.052 -1.864 -0.8666
EBIT 1 -0.0684 0.1624 -0.0247 -0.0602 -1.9 -0.9267
Operating Margin -28.88% 21.13% -4.07% - -7,342.85% -808.63%
Earnings before Tax (EBT) 1 -0.0763 0.1412 -0.321 -3.169 -2.701 -4.756
Net income 1 -0.0763 0.1027 -0.321 -3.143 -2.701 -4.756
Net margin -32.21% 13.36% -53.02% - -10,438.36% -4,149.98%
EPS 2 -0.000431 0.000151 -0.001780 -0.0136 -0.009430 -0.006169
Free Cash Flow 1 -0.27 0.1529 -0.1574 -0.0008 0.7802 -
FCF margin -114% 19.89% -26% - 3,015.54% -
FCF Conversion (EBITDA) - 75.22% - - - -
FCF Conversion (Net income) - 148.84% - - - -
Dividend per Share - - - - - -
Announcement Date 12/28/18 10/15/19 5/4/21 10/12/21 10/13/22 1/17/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 0.45 0.28 0.53 0.31 0.65 1.83
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -7.975 x 1.397 x 11.31 x -6.038 x -0.3495 x -2.111 x
Free Cash Flow 1 -0.27 0.15 -0.16 -0 0.78 -
ROE (net income / shareholders' equity) -1,504% 218% -404% 2,850% 335% 160%
ROA (Net income/ Total Assets) -15.6% 17.6% -2.09% -7.63% -395% -209%
Assets 1 0.488 0.5825 15.34 41.21 0.6828 2.274
Book Value Per Share 2 -0 0 0 -0 -0.0100 -0
Cash Flow per Share 2 0 0 0 0 0 -
Capex 1 0.2 0.06 0.26 0.02 0.08 0.08
Capex / Sales 83.3% 7.51% 42.32% - 292.27% 71.83%
Announcement Date 12/28/18 10/15/19 5/4/21 10/12/21 10/13/22 1/17/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
FORZA INNOVATIONS INC. Stock Forza Innovations Inc.
-66.67% 252K
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.54% 187B
MEDTRONIC PLC Stock Medtronic plc
-1.85% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.26% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+1.39% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+16.82% 48B
HOYA CORPORATION Stock Hoya Corporation
+6.30% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.49% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.65% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+16.75% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. FORZ Stock
  4. Financials Forza Innovations Inc.